Shenzhen - Delayed Quote CNY
China National Accord Medicines Corporation Ltd. (000028.SZ)
25.17
+0.02
+(0.08%)
At close: May 23 at 3:04:12 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
73,581,533
74,378,494.39
75,477,484.62
73,443,136.99
68,357,809.57
Cost of Revenue
65,513,225.86
66,129,208.57
66,425,425.56
64,516,926.01
60,339,298.05
Gross Profit
8,068,307.14
8,249,285.82
9,052,059.06
8,926,210.98
8,018,511.52
Operating Expense
6,458,520.41
6,575,515.98
6,552,699.07
6,513,741.20
5,864,548.07
Operating Income
1,609,786.73
1,673,769.84
2,499,359.99
2,412,469.78
2,153,963.45
Net Non Operating Interest Income Expense
-230,239.77
-237,574.39
-207,489.33
-189,077.21
-212,897.31
Pretax Income
463,547
575,469.44
2,473,226.54
2,311,070.12
1,974,852.85
Tax Provision
324,989.23
338,465.91
514,739.44
539,332.13
447,210.65
Net Income Common Stockholders
581,721.23
642,493.45
1,599,255.76
1,486,707.65
1,336,427.75
Basic EPS
1.04
1.15
2.87
2.67
2.40
Diluted EPS
1.04
1.15
2.87
2.67
2.40
Basic Average Shares
558,825.69
558,689.96
557,231.97
556,819.35
556,844.90
Diluted Average Shares
558,825.69
558,689.96
557,231.97
556,819.35
556,844.90
Total Operating Income as Reported
468,615.36
573,478.28
2,467,425.16
2,306,068.62
1,952,411.26
Rent Expense Supplemental
--
14,144.41
20,008.62
24,785.35
31,250.66
Total Expenses
71,971,746.28
72,704,724.55
72,978,124.63
71,030,667.21
66,203,846.12
Net Income from Continuing & Discontinued Operation
581,721.23
642,493.45
1,599,255.76
1,486,707.65
1,336,427.75
Normalized Income
1,318,066.30
1,540,148.63
1,688,378.71
1,651,851.17
1,590,811.85
Interest Income
54,583.10
58,523.38
77,554.16
72,935.65
74,297.77
Interest Expense
247,184.57
258,301.91
248,381.40
261,908.26
288,038.76
Net Interest Income
-230,239.77
-237,574.39
-207,489.33
-189,077.21
-212,897.31
EBIT
710,731.57
833,771.34
2,721,607.95
2,572,978.38
2,262,891.61
EBITDA
710,731.57
2,379,121
4,147,262.72
3,880,404.22
3,531,072.25
Reconciled Cost of Revenue
65,513,225.86
66,129,208.57
66,425,425.56
64,516,926.01
60,339,298.05
Reconciled Depreciation
--
1,545,349.66
1,425,654.77
1,307,425.84
1,268,180.64
Net Income from Continuing Operation Net Minority Interest
581,721.23
642,493.45
1,599,255.76
1,486,707.65
1,336,427.75
Total Unusual Items Excluding Goodwill
-1,227,241.77
-1,196,873.57
-112,546.69
-215,414.61
-328,853.94
Total Unusual Items
-1,227,241.77
-1,196,873.57
-112,546.69
-215,414.61
-328,853.94
Normalized EBITDA
1,937,973.34
3,575,994.58
4,259,809.41
4,095,818.83
3,859,926.19
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-490,896.71
-299,218.39
-23,423.74
-50,271.09
-74,469.84
12/31/2021 - 6/8/1993
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade